資料載入中.....
|
請使用永久網址來引用或連結此文件:
http://ir.cmu.edu.tw/ir/handle/310903500/30267
|
| 題名: | Effects of patient demographics, risperidone dosage, and clinical outcome on body weight in acutely exacerbated schizophrenia |
| 作者: | Lane, HY;Chang, YC;Cheng, YC;Liu, GC;Lin, XR;Chang, WH |
| 貢獻者: | 附設醫院精神醫學部;Tzu Chi Univ, Dept Psychiat, Hualien 970, Taiwan;China Med Coll Hosp, Dept Psychiat, Taichung, Taiwan;Tamkang Univ, Dept Math, Taipei, Taiwan;Mil Hualien Gen Hosp, Dept Psychiat, Hualien, Taiwan;Dalin Tzu Chi Gen Hosp, Hualien, Taiwan |
| 日期: | 2003 |
| 上傳時間: | 2010-09-24 14:52:13 (UTC+8) |
| 出版者: | PHYSICIANS POSTGRADUATE PRESS |
| 摘要: | Asthma is a hyperresponsive airway disease that may involve inflammation responses. A transporter associated with the antigen processing 1 gene (TAP1) is involved in antigen processing, and is therefore considered to play a role in the pathogenesis of bronchial asthma. The aim of this study was to test whether the polymorphisms of the TAP1 gene are a genetic marker for susceptibility to bronchial asthma. A normal control group comprised of 43 healthy people, and 116 patients with allergic asthma were examined in this study. The polymorphism was detected by polymerase chain reaction (PCR)-based restriction analysis. Associations between atopic bronchial asthma and TAP1 polymorphisms were evaluated. The results revealed no significant differences between normal individuals and asthmatics in regard to the TAP1 gene Dpnll polymorphism (P=0.752). However, there was a significant difference between the control and asthma groups as regards the TAP1 gene Accl polymorphism (P=0.020). The odds ratio (OR) of GG homozygotes of the TAP1 Accl polymorphism was 229.8 compared with the AA homozygote group. The results show that the Accl polymorphism may be an indicator for atopic bronchial asthma. J. Clin. Lab. Anal. 17:57-60, 2003. (C) 2003 Wiley-Liss, Inc. |
| 關聯: | JOURNAL OF CLINICAL PSYCHIATRY 64(3):316-320 |
| 顯示於類別: | [台中附設醫院] 期刊論文
|
在CMUR中所有的資料項目都受到原著作權保護.
|
